Nguyen Integrative Medicine
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Migraine Treatment
Read the Migraine Treatment guide for the educational context behind this treatment category.
Pennsylvania
Most migraine treatment capacity in Pennsylvania sits in two metro areas: Philadelphia in the southeast and Pittsburgh in the southwest, where neurology departments and headache specialty practices concentrate. Smaller clusters exist around the Lehigh Valley and the Harrisburg area, but coverage elsewhere is thin. Someone searching from a South Hills community like Brentwood, outside Pittsburgh's core, is generally looking at a short drive into the city, and rural counties elsewhere often travel farther to reach a neurologist who treats migraine as an ongoing condition.
Pennsylvania licenses physicians, physician assistants, and nurse practitioners separately, and migraine treatment here is generally delivered from a physician's office or hospital affiliated clinic rather than a wellness setting, since preventive injections, nerve blocks, and infused medications are prescribed by a neurologist or headache specialist, or administered by a physician assistant or nurse practitioner under one. Exactly who can prescribe, supervise, or administer a given therapy follows the state's scope of practice rules, so confirm current rules with the boards below.
To verify a provider in Pennsylvania, check the Pennsylvania State Board of Medicine for a physician's or physician assistant's license and history, and the Pennsylvania State Board of Nursing for a nurse practitioner's standing. A clean record confirms licensure and shows any public disciplinary action; it will not tell you whether a therapy fits your case or how a clinic prices its care.
Before booking anywhere in the state, ask who will administer any injection or infusion and what training they hold, what is being given and where it comes from, how risks are disclosed in writing, what happens if a first approach does not help, and whether a quote itemizes the visit separately from the procedure.
The order clinics appear in this listing is not paid ranking; it reflects each clinic's own profile information. Any Featured placement is labeled and capped rather than blended invisibly into the list, and a Verified badge means a clinic's credentials were checked, not that it paid for a better position. Regenerated.com is free for patients to use, and being listed here is not an endorsement of any clinic.
For how migraine treatment works and what the evidence actually supports, see the national migraine treatment hub on this site. For more on how this directory itself is built, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Pennsylvania State Board of Medicine and the Board of Osteopathic Medicine investigate TMS clinics for supervision lapses and off-label marketing. The Pennsylvania attorney general enforces the Unfair Trade Practices and Consumer Protection Law against deceptive medical device advertising, including neurofeedback cure claims. Wellness clinics offering CES or tDCS face scrutiny when marketing implies FDA-cleared medical treatment. Commercial insurers and Pennsylvania Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.
More in this state
Nationwide
Migraine Treatment clinics across the US